Flamma SpA, a CDMO that develops, manufactures, and commercializes small molecule Active Pharmaceutical Ingredients (APIs) for the pharmaceutical industry, recently broke ground for a new R&D building in Chignolo d’Isola, Bergamo, Italy. The expansion at Flamma’s headquarters will allow the company to quadruple its R&D space. The new facility will accommodate 50 additional employees, additional R&D and analytical development laboratories, as well as offices and meeting rooms. Add...